These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11705853)
1. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853 [TBL] [Abstract][Full Text] [Related]
2. Human kallikrein 10, a predictive marker for breast cancer. Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732 [TBL] [Abstract][Full Text] [Related]
3. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Liu XL; Wazer DE; Watanabe K; Band V Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136 [TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related]
6. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155 [TBL] [Abstract][Full Text] [Related]
7. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V Cancer Res; 2001 Nov; 61(21):8014-21. PubMed ID: 11691827 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
9. KAI1 protein is down-regulated during the progression of human breast cancer. Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724 [TBL] [Abstract][Full Text] [Related]
10. The role for NES1 serine protease as a novel tumor suppressor. Goyal J; Smith KM; Cowan JM; Wazer DE; Lee SW; Band V Cancer Res; 1998 Nov; 58(21):4782-6. PubMed ID: 9809976 [TBL] [Abstract][Full Text] [Related]
11. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Luo LY; Rajpert-De Meyts ER; Jung K; Diamandis EP Br J Cancer; 2001 Jul; 85(2):220-4. PubMed ID: 11461080 [TBL] [Abstract][Full Text] [Related]
12. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
13. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453 [TBL] [Abstract][Full Text] [Related]
14. BigH3 protein expression as a marker for breast cancer. Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347 [TBL] [Abstract][Full Text] [Related]
15. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland. Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Zhu XL; Hartwick W; Rohan T; Kandel R Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206 [TBL] [Abstract][Full Text] [Related]
17. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825 [TBL] [Abstract][Full Text] [Related]
18. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities. Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258 [TBL] [Abstract][Full Text] [Related]
19. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093 [TBL] [Abstract][Full Text] [Related]
20. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]